Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,272
Sort by:

Malignant Pleural Effusion (Respiratory) - Drugs In Development, 2021

US$ 2,000.00

Malignant Pleural Effusion (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Effusion - Drugs In...

July 2021 54 pages

Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Marbur...

July 2021 122 pages

Measles (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Measles (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Measles - Drugs In Development, 2021, provides an...

July 2021 53 pages

Melanocortin Receptor 4 - Drugs In Development, 2021

US$ 3,500.00

Melanocortin Receptor 4 - Drugs In Development, 2021 SUMMARY Melanocortin Receptor 4 (MC4R) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by...

July 2021 88 pages

Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021

US$ 3,500.00

Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021 SUMMARY Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Melanocyte-stimulating hormone receptor...

July 2021 86 pages

Metabotropic Glutamate Receptor 1 - Drugs In Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 1 - Drugs In Development, 2021 SUMMARY Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) pipeline Target constitutes close to 5 molecules. Out of which appro...

July 2021 28 pages

Metabotropic Glutamate Receptor 7 - Drugs In Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 7 - Drugs In Development, 2021 SUMMARY Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) - Metabotropic glutamate receptor 7 is a protein encoded by the GRM7...

July 2021 36 pages

Mild Cognitive Impairment (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Mild Cognitive Impairment (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment -...

July 2021 202 pages

Myc Proto Oncogene Protein - Drugs In Development, 2021

US$ 3,500.00

Myc Proto Oncogene Protein - Drugs In Development, 2021 SUMMARY Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes cl...

July 2021 69 pages

Myocardial Infarction (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Myocardial Infarction (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Drugs In Develop...

July 2021 439 pages

Narcolepsy (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Narcolepsy (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Drugs In Development, 2021, pr...

July 2021 118 pages

Nasopharyngeal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Nasopharyngeal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Drugs In Development,...

July 2021 853 pages

Neisseria meningitidis Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Neisseria meningitidis Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neisseria meningitidis I...

July 2021 105 pages

Neurofibromatoses Type II (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Neurofibromatoses Type II (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II -...

July 2021 67 pages

Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuromyelitis...

July 2021 187 pages

Neuronal Acetylcholine Receptor Subunit Alpha 4 - Drugs In Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 4 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Neuronal Acetylcholine Receptor Subunit Alpha 4 - Drugs In Development,...

July 2021 62 pages

Neutropenia (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Neutropenia (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia - Drugs In Development, 2021, provides an...

July 2021 150 pages

Nociceptin Receptor - Drugs In Development, 2021

US$ 3,500.00

Nociceptin Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Nociceptin Receptor - Drugs In Development, 2021'; Nociceptin Receptor (Kappa Type 3 Opioid Recepto...

July 2021 58 pages

Ocular Hypertension (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Ocular Hypertension (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Drugs In Development,...

July 2021 169 pages

Oligodendroglioma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Oligodendroglioma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Drugs In Development, 2021, pr...

July 2021 201 pages

Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Dr...

July 2021 249 pages

Optic Neuropathy (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Optic Neuropathy (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuropathy - Drugs In Development, 2021,...

July 2021 64 pages

Oral Mucositis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,000.00

Oral Mucositis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oral Mucositis - Drugs In Development, 2021,...

July 2021 71 pages

Orexin Receptor Type 1 - Drugs In Development, 2021

US$ 3,500.00

Orexin Receptor Type 1 - Drugs In Development, 2021 SUMMARY Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Orexin receptor type 1 (Ox1R or OX1) is a protein that is encoded by the HCR...

July 2021 85 pages

Orexin Receptor Type 2 - Drugs In Development, 2021

US$ 3,500.00

Orexin Receptor Type 2 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Orexin Receptor Type 2 - Drugs In Development, 2021'; Orexin Receptor Type 2 (Hypocretin Recepto...

July 2021 97 pages

Osteoarthritis (Musculoskeletal) - Drugs In Development, 2021

US$ 2,500.00

Osteoarthritis (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Drugs In Development, 2021, p...

July 2021 480 pages

Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain - Drugs In Dev...

July 2021 291 pages

Osteosarcoma (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Osteosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteosarcoma - Drugs In Development, 2021, provides an...

July 2021 1205 pages

Overactive Bladder (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Overactive Bladder (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Drugs In Deve...

July 2021 126 pages

Pancreatic Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Pancreatic Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Drugs In Development, 2021, pr...

July 2021 5249 pages

Pancreatitis (Gastrointestinal) - Drugs In Development, 2021

US$ 2,000.00

Pancreatitis (Gastrointestinal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Drugs In Development, 2021, prov...

July 2021 121 pages

Paroxysmal Nocturnal Hemoglobinuria (Hematology) - Drugs In Development, 2021

US$ 2,000.00

Paroxysmal Nocturnal Hemoglobinuria (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobi...

July 2021 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021

US$ 2,000.00

Peanut Allergy (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provid...

July 2021 176 pages

Periodontitis (Mouth and Dental Disorders) - Drugs In Development, 2021

US$ 2,000.00

Periodontitis (Mouth and Dental Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Periodontitis - Drugs In Development...

July 2021 59 pages

Peritoneal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,500.00

Peritoneal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Drugs In Development, 2021, pr...

July 2021 2212 pages

Plasminogen Activator Inhibitor 1 - Drugs In Development, 2021

US$ 3,500.00

Plasminogen Activator Inhibitor 1 - Drugs In Development, 2021 SUMMARY Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Plasminogen activator inhib...

July 2021 74 pages

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease -...

July 2021 172 pages

Polycystic Ovarian Syndrome (Women's and Male Health) - Drugs In Development, 2021

US$ 2,000.00

Polycystic Ovarian Syndrome (Women's and Male Health) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndro...

July 2021 60 pages

Polycythemia Vera (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Polycythemia Vera (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Drugs In Development, 2021, pr...

July 2021 142 pages

Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera...

July 2021 550 pages

Premature Labor (Tocolysis) (Women's and Male Health) - Drugs In Development, 2021

US$ 2,000.00

Premature Labor (Tocolysis) (Women's and Male Health) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premature Labor - Drugs I...

July 2021 61 pages

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021

US$ 2,000.00

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Dia...

July 2021 68 pages

Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Vitreoretin...

July 2021 43 pages

Pseudomonas aeruginosa Pneumonia (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Pseudomonas aeruginosa Pneumonia (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Pn...

July 2021 36 pages

Psoriasis (Immunology) - Drugs In Development, 2021

US$ 2,500.00

Psoriasis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Drugs In Development, 2021, provides an over...

July 2021 1178 pages

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertensio...

July 2021 426 pages

Pyelonephritis (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Pyelonephritis (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Drugs In Development, 2021...

July 2021 155 pages

Radiation Toxicity - Drugs In Development, 2021

US$ 2,000.00

Radiation Toxicity - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Synd...

July 2021 337 pages

Rectal Cancer (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Rectal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2021, provides a...

July 2021 417 pages

Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseu...

July 2021 53 pages

Filters

Search

Categories

153
14,653
11,965
339
73
1,089

Publishers

72
1
1,760
342
531
292
33
4
1,887
635
92
3,251
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,666

Price

—

Date

—

Pages

—

Offers

44
5
1